Central Executive Training (CET) for ADHD
Central Executive Training for ADHD: Efficacy Trial
1 other identifier
interventional
251
1 country
1
Brief Summary
The goal of the current project is to assess the efficacy of Central Executive Training (CET) for youth with ADHD. CET is a new, computerized training intervention that targets specific components of the working memory system. Two versions of CET were developed as part of our R34, each targeting a different combinations of executive functions. The final CET protocol reflects the contributions and feedback of a diverse group of caregivers, children with ADHD, and recognized experts in human cognition, ADHD treatment research, randomized control trial (RCT) intervention design methods, serious game theory and task design, cognitive training, and the role of executive dysfunction in ADHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2017
CompletedFirst Posted
Study publicly available on registry
October 27, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2024
CompletedMarch 7, 2025
March 1, 2025
6 years
October 9, 2017
March 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
ADHD symptoms
Average of T-scores on parent-report ADHD symptoms questionnaires (Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-5) Inattention and Hyperactivity subscales, Behavioral Assessment System for Children (BASC-3) Inattention and Hyperactivity subscales)
Immediate post-treatment (within 2 weeks of final treatment session)
Secondary Outcomes (4)
Working Memory
Immediate post-treatment (within 2 weeks of final treatment session)
Inhibitory control
Immediate post-treatment (within 2 weeks of final treatment session)
Actigraph-measured hyperactivity during working memory testing
Immediate post-treatment (within 2 weeks of final treatment session)
Actigraph-measured hyperactivity during baseline
Immediate post-treatment (within 2 weeks of final treatment session)
Other Outcomes (12)
NIH List Sorting
Follow-up testing: 2-4 months after the post-treatment evaluation (variable time frame to account for school breaks)
Teacher-reported ADHD symptoms
Immediate post-treatment (within 2 weeks of final treatment session)
Academic performance rating scale (APRS)
Immediate post-treatment (within 2 weeks of final treatment session)
- +9 more other outcomes
Study Arms (2)
CET-Working Memory (WM)
EXPERIMENTALCentral Executive Training: Working Memory
CET-Behavioral Inhibition (BI)
ACTIVE COMPARATORCentral Executive Training: Inhibitory Control
Interventions
Computerized working memory training
Computerized inhibitory control training
Eligibility Criteria
You may qualify if:
- Children ages 8-12 with principal ADHD diagnoses (via Kiddie Schedule for Affective Disorders semi-structured clinical interviewing (K-SADS)
- Parent AND teacher ratings in clinical/borderline range based on age and gender on ADHD-RS-5 or BASC-3 Attention Problems/Hyperactivity subscales
- Below average or lower working memory on at least one pre-treatment WM test. All ADHD presentations will be eligible.
You may not qualify if:
- gross neurological, sensory, or motor impairment
- history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with study participation (substance use, disruptive mood dysregulation, intermittent explosive, reactive attachment)
- intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form intelligence quotient (FSIQ) \< 78 (1.5 standard deviations (SD) below mean)
- conditions requiring acute intervention, e.g., active suicidality
- non-English speaking child or parent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florida State University
Tallahassee, Florida, 32306, United States
Related Publications (1)
Groves NB, Chan ESM, Marsh CL, Gaye F, Jaisle EM, Kofler MJ. Does central executive training and/or inhibitory control training improve emotion regulation for children with attention-deficit/hyperactivity disorder? A randomized controlled trial. Front Psychiatry. 2022 Dec 6;13:1034722. doi: 10.3389/fpsyt.2022.1034722. eCollection 2022.
PMID: 36561637DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 9, 2017
First Posted
October 27, 2017
Study Start
January 1, 2018
Primary Completion
December 31, 2023
Study Completion
January 5, 2024
Last Updated
March 7, 2025
Record last verified: 2025-03